About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 529 record(s)
Req # A-2021-001290
All ProServices contracts issued in the National Capital Region for the months of January 2021 to September 2021.Organization: Health Canada
August 2023
Req # A-2021-002048
Copies of Natural Product Number (NPN) Product Licence Application (PLA) application as well as all correspondence, review documents, notes and discussions relating to NPN 80106548.Organization: Health Canada
August 2023
Req # A-2022-000268
Regarding this announcement: https://www.canada.ca/en/health-canada/news/2022/05/government-of-canada-strengthens-access-to-abortion-services.html "National Abortion Federation (NAF) Canada will receive $1,469,150 in funding over three years, to provide financial and logistical support to women seeking abortion services, train health care providers in providing abortion services, and ensure abortion facilities have the capacity to continue to provide services and related care." All records internal to Health Canada, all records to and from any external government departments and the Prime Minister's Office (PMO), and all records to and from NAF, which led to the decision to grant this funding to NAF Canada.Organization: Health Canada
August 2023
Req # A-2022-000452
According to the Health Canada Generic Submissions Under Review List (updated June 22, 2022), Health Canada is currently reviewing an Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate. The month and year that the Desmopressin ANDS was accepted into review and the status of the Desmopressin ANDS review.Organization: Health Canada
August 2023
Req # A-2022-000978
The medical device application for the MonaLisa Touch device (Licence #95941, first issue date 2015-10-16, device identifier M103P1/M110C1). A medical device application form should have been submitted, and review documents should have accompanied this application. Copies of both the application form, and the review documents.Organization: Health Canada
August 2023
Req # A-2022-001242
All communications with Twitter regarding any discussions/requests to censor/suspend/ban/promote/throttle/shadow ban an account or particular post, since January 1, 2020.Organization: Health Canada
August 2023
Req # A-2022-001243
All information regarding position number 94968 including the classification record from the form TB330-167 where all scores of factors are provided as well as total for determination of classification level. All information from communications from within Heath Canada and any classification officers that worked on position number 94968.Organization: Health Canada
August 2023
Req # A-2023-000023
The initial cover letter and any other document indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” for the medicinal ingredient Propranolol hydrochloride. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for Propranolol hydrochloride. The strength (s) and dosage form of any and all generic drugs in Health Canada’s list of “Generic Drug Submissions Under Review” for the medicinal ingredient Propranolol hydrochloride.Organization: Health Canada
August 2023
Req # A-2023-000051
All written communications between the Abortion Rights Coalition of Canada, as per the recent entry into the lobbyist database as detailed below from 2023-01-17 to 2023-04-12. Subject Matter of the communication: Health Communication date: 2023-01-17 Posted date: 2023-01-17 Communication number: 357176-554492.Organization: Health Canada
August 2023
Req # A-2023-000156
The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Pharmacovigilance Practices (GVP) inspection of the Organon Canada facility (Site A) on route Transcanadienne, Kirkland, Ontario starting around 6 February 2023. Reference Number 511240.Organization: Health Canada
August 2023